NLRP3 inflammasome involves in the pathophysiology of sepsis-induced myocardial dysfunction by multiple mechanisms

Area of Science:

• Cardiovascular Medicine
• Immunology
• Molecular Biology

Background:

• Sepsis-induced myocardial dysfunction (SIMD) is a critical global health issue with unclear mechanisms.
• The NOD-like receptor protein 3 (NLRP3) inflammasome is implicated in SIMD pathophysiology.
• NLRP3 inflammasome signaling influences inflammation, autophagy, apoptosis, and pyroptosis in SIMD.

Purpose of the Study:

• To review the role of the NLRP3 inflammasome in SIMD.
• To explore potential therapeutic strategies targeting the NLRP3 inflammasome for SIMD treatment.

Main Methods:

• Literature review of studies investigating NLRP3 inflammasome in SIMD.
• Analysis of experimental data on NLRP3 inflammasome inhibitors in SIMD models.

Main Results:

• NLRP3 inflammasome activation is a key factor in SIMD.
• Specific NLRP3 inhibitors (e.g., Melatonin, Ulinastatin) demonstrate anti-inflammatory effects in SIMD models.
• These findings suggest NLRP3 inflammasome as a potential therapeutic target.

Conclusions:

• The NLRP3 inflammasome plays a significant role in the development of SIMD.
• NLRP3 inflammasome inhibitors represent a promising avenue for SIMD therapy.
• Further preclinical and in vivo studies are necessary for clinical translation.